Targeted strategies to deliver boron agents across the blood-brain barrier for neutron capture therapy of brain tumors.
Int J Pharm
; 650: 123747, 2024 Jan 25.
Article
in En
| MEDLINE
| ID: mdl-38151104
ABSTRACT
Boron neutron capture therapy (BNCT), as an innovative radiotherapy technology, has demonstrated remarkable outcomes when compared to conventional treatments in the management of recurrent and refractory brain tumors. However, in BNCT of brain tumors, the blood-brain barrier is a main stumbling block for restricting the transport of boron drugs to brain tumors, while the tumor targeting and retention of boron drugs also affect the BNCT effect. This review focuses on the recent development of strategies for delivering boron drugs crossing the blood-brain barrier and targeting brain tumors, providing new insights for the development of efficient boron drugs for the treatment of brain tumors.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Boron Neutron Capture Therapy
/
Glioma
Limits:
Humans
Language:
En
Journal:
Int J Pharm
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands